Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 76 - 78 of 78 in total

Fimasartan

Fimasartan is an angiotensin II receptor antagonist (ARB) drug employed in the treatment of both hypertension and heart failure. It has been found to be safe when administered with hydrochlorothiazide (a diuretic) in clinical trials. Fimasartan was initially approved September 9th, 2010 in South Korea and is marketed under the...
Investigational
Matched Description: … is an angiotensin II receptor antagonist (ARB) drug employed in the treatment of both hypertension and ... Fimasartan was initially approved September 9th, 2010 in South Korea and is marketed under the brand …
Matched Salts name: … Fimasartan potassium anhydrous …
Matched Categories: … fimasartan and diuretics ... fimasartan and amlodipine ... rosuvastatin and fimasartan ... Angiotensin II receptor blockers (ARBs) and diuretics ... Angiotensin II receptor blockers (ARBs) and calcium channel blockers …

Zomepirac

Zomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions. The manufacturer voluntarily removed Zomax tablets from the Canadian, US, and UK markets in March 1983.
Withdrawn
Matched Description: … Zomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid ... The manufacturer voluntarily removed Zomax tablets from the Canadian, US, and UK markets in March 1983 …
Matched Salts name: … Zomepirac sodium anhydrous ... Zomepirac sodium …
Matched Categories: … Acetic Acid Derivatives and Related Substances ... Antiinflammatory and Antirheumatic Products ... Antiinflammatory and Antirheumatic Products, Non-Steroids …

Menadione bisulfite

Experimental
Matched Salts name: … Menadione sodium bisulfite anhydrous ... Menadione sodium bisulfite trihydrate …
Matched Categories: … Diet, Food, and Nutrition …
Displaying drugs 76 - 78 of 78 in total